Alcon is a medical instruments & supplies business based in the US. Alcon shares (ALC) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $85.43 – a decrease of 2.35% over the previous week. Alcon employs 25,000 staff and has a trailing 12-month revenue of around $9.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $85.43 |
|---|---|
| 52-week range | $70.63 - $101.10 |
| 50-day moving average | $95.66 |
| 200-day moving average | $88.82 |
| Wall St. target price | $100.60 |
| PE ratio | 39.4306 |
| Dividend yield | $0 (0.3%) |
| Earnings per share (TTM) | $2.16 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $85.81 from 2024-11-18
| 1 week (2024-11-13) | -1.92% |
|---|---|
| 1 month (2024-10-18) | -9.81% |
| 3 months (2024-08-20) | -11.08% |
| 6 months (2024-05-20) | -2.60% |
| 1 year (2023-11-20) | 20.54% |
|---|---|
| 2 years (2022-11-18) | 31.45% |
| 3 years (2021-11-19) | 5.09% |
| 5 years (2019-11-20) | 52.67% |
Valuing Alcon stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alcon's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Alcon's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 39x. In other words, Alcon shares trade at around 39x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Alcon's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.2171. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Alcon's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Alcon's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.4 billion.
The EBITDA is a measure of a Alcon's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $9.8 billion |
|---|---|
| Operating margin TTM | 13.53% |
| Gross profit TTM | $4.8 billion |
| Return on assets TTM | 2.55% |
| Return on equity TTM | 5.59% |
| Profit margin | 11.89% |
| Book value | $43.25 |
| Market Capitalization | $42.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 9.64% of net profits
Recently Alcon has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Alcon shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Alcon's case, that would currently equate to about $0 per share.
While Alcon's payout ratio might seem low, this can signify that Alcon is investing more in its future growth.
Alcon's most recent dividend payout was on 15 May 2024. The latest dividend was paid out to all shareholders who bought their shares by 13 May 2024 (the "ex-dividend date").
Over the last 12 months, Alcon's shares have ranged in value from as little as $70.6282 up to $101.1. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Alcon's is 0.73. This would suggest that Alcon's shares are less volatile than average (for this exchange).
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S. A.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.